Top Brand
Salt CompositionOur Recommendation
Ivabrad OD 10mg Tablet PR 10s
220+ trust this
WHO GMP Certified
220+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Angina (heart-related chest pain) / Treatment of Heart failure
Customers also bought
More About Ivabrad
Benefits
In Treatment of Angina (heart-related chest pain) Ivabrad OD 10 Tablet PR is a heart rate lowering medication. It works by slowing down your heart rate. This lowers the heart?s need for oxygen, making it less likely that you will suffer chest pain. The medicine can reduce the frequency of angina attacks and help increase your ability to exercise and go about your daily life more efficiently. You should not stop taking it without your doctor?s advice, even if you feel well. In Treatment of Heart failure Heart failure is a condition where your heart cannot pump enough blood to the rest of your body. Ivabrad OD 10 Tablet PR can be used in combination with other medicines to improve symptoms such as breathlessness, tiredness, and swelling and prevent heart failure from getting worse. This will improve your quality of life, allow you to go about your daily activities more easily, and decreases the risk of hospitalization in heart failure patients. This medicine needs to be taken regularly to be effective. Do not stop taking it until the doctor tells you so, even if you feel well.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Use it as advised by your doctor or check the label for directions before use. Ivabrad OD 10 Tablet PR is to be taken with food.
How it works
Ivabrad OD 10 Tablet PR is a heart rate lowering medication. It works by reducing the heart rate which lowers the oxygen requirement of the heart. As a result, the heart works more efficiently.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Ivabrad OD 10 Tablet PR . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Ivabrad OD 10 Tablet PR is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Ivabrad OD 10 Tablet PR during breastfeeding is not available. Doctor consultation is advised.
Not Safe: Ivabrad OD 10 Tablet PR may cause side effects which could affect your ability to drive. Ivabrad OD 10 Tablet PR may cause transient luminous phenomena consisting mainly of phosphenes. The possible occurrence of such luminous phenomena should be taken into account especially when driving at night.
Caution Advised: Ivabrad OD 10 Tablet PR should be used with caution in patients with severe kidney disease. Dose adjustment of Ivabrad OD 10 Tablet PR may be needed. Doctor consultation is advised. Limited information is available for use of Ivabrad OD 10 Tablet PR in patients with severe kidney disease.
Caution Advised: Ivabrad OD 10 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Ivabrad OD 10 Tablet PR may be needed. Doctor consultation is advised. Use of Ivabrad OD 10 Tablet PR is not recommended in patients with severe liver disease.
What if I forget to take it?
If you forget a dose of Ivabrad OD 10 Tablet PR , simply continue with your regular schedule and do not take a double dose.
Manufacturer Address
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India
References
Opie LH, Horowitz JD. Nitrates and Newer Antianginals ?-Blocking Agents. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 57
Katzung BG, Chatterjee K. Vasodilator & the Treatment of Angina Pectoris. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 203-204
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Ivabradine (07 Jul. 2023)
Ivabradine (24 Mar. 2025)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
